INVEGA SUSTENNA

Janssen Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 15, 2022
Approval ID: 1af14e42-951d-414d-8564-5d5fce138554
Products: 5 registered
Version: 37

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use INVEGA SUSTENNA safely and effectively. See full prescribing information for INVEGA SUSTENNA. INVEGA SUSTENNA (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006

Quick Stats

Total Products5

Labelers2

Label Sections25

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.